Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageDebt RatioDebt to EquityEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginGross MarginInterest Coverage RatioInventory AverageInvested CapitalMarket CapitalizationNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on SalesTimes Interest Earned

Journey Medical (DERM) Invested Capital: 2020-2024

Historic Invested Capital for Journey Medical (DERM) over the last 5 years, with Dec 2024 value amounting to $44.9 million.

  • Journey Medical's Invested Capital rose 2.64% to $31.5 million in Q3 2025 from the same period last year, while for Sep 2025 it was $31.5 million, marking a year-over-year increase of 2.64%. This contributed to the annual value of $44.9 million for FY2024, which is 28.53% up from last year.
  • According to the latest figures from FY2024, Journey Medical's Invested Capital is $44.9 million, which was up 28.53% from $35.0 million recorded in FY2023.
  • Journey Medical's 5-year Invested Capital high stood at $44.9 million for FY2024, and its period low was $10.3 million during FY2020.
  • Its 3-year average for Invested Capital is $41.6 million, with a median of $44.7 million in 2022.
  • In the last 5 years, Journey Medical's Invested Capital surged by 316.39% in 2021 and then fell by 21.85% in 2023.
  • Journey Medical's Invested Capital (Yearly) stood at $10.3 million in 2020, then surged by 316.39% to $42.9 million in 2021, then rose by 4.41% to $44.7 million in 2022, then dropped by 21.85% to $35.0 million in 2023, then climbed by 28.53% to $44.9 million in 2024.